2014
Case 29-2013: An HIV-positive man with dyspnea and skin lesions.
Friedland GH. Case 29-2013: An HIV-positive man with dyspnea and skin lesions. New England Journal Of Medicine 2014, 370: 88. PMID: 24382080, DOI: 10.1056/nejmc1313214.Peer-Reviewed Original ResearchHIV SeropositivityHIV-1HumansImmune Reconstitution Inflammatory SyndromeLung NeoplasmsMaleSarcoma, KaposiSkin Neoplasms
2013
Case 29-2013 — A 32-Year-Old HIV-Positive African Man with Dyspnea and Skin Lesions
Cabot R, Rosenberg E, Harris N, Shepard J, Cort A, Ebeling S, McDonald E, Friedland G, Naidoo P, Abdool-Gafoor B, Moosa M, Ramdial P, Gandhi R. Case 29-2013 — A 32-Year-Old HIV-Positive African Man with Dyspnea and Skin Lesions. New England Journal Of Medicine 2013, 369: 1152-1161. PMID: 24047065, DOI: 10.1056/nejmcpc1305985.Peer-Reviewed Original Research
2012
The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.
Naidoo K, Yende-Zuma N, Padayatchi N, Naidoo K, Jithoo N, Nair G, Bamber S, Gengiah S, El-Sadr WM, Friedland G, Abdool Karim S. The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial. Annals Of Internal Medicine 2012, 157: 313-24. PMID: 22944873, PMCID: PMC3534856, DOI: 10.7326/0003-4819-157-5-201209040-00004.Peer-Reviewed Original ResearchMeSH KeywordsAdultAIDS-Related Opportunistic InfectionsAntibiotics, AntitubercularAnti-Retroviral AgentsCD4 Lymphocyte CountFemaleHIV InfectionsHumansImmune Reconstitution Inflammatory SyndromeImmunocompromised HostIncidenceKaplan-Meier EstimateMaleProspective StudiesRifampinRisk FactorsSeverity of Illness IndexTuberculosisConceptsImmune reconstitution inflammatory syndromeSequential treatment groupIncidence of IRISReconstitution inflammatory syndromeAntiretroviral therapy initiationART initiationTreatment groupsIRIS incidenceSAPiT trialInflammatory syndromeTherapy initiationTreatment initiationTuberculosis treatmentOpen-label clinical trialCells/LCo-infected patientsEarly ART initiationInitiation of ARTTuberculosis treatment initiationSmear-negative tuberculosisHigher hospitalization ratesWeeks of completionBaseline CD4Antituberculosis treatmentNonambulatory patients
2009
Tuberculosis Immune Reconstitution Inflammatory Syndrome: Drug Resistance and the Critical Need for Better Diagnostics
Friedland G. Tuberculosis Immune Reconstitution Inflammatory Syndrome: Drug Resistance and the Critical Need for Better Diagnostics. Clinical Infectious Diseases 2009, 48: 677-679. PMID: 19191656, DOI: 10.1086/596765.Peer-Reviewed Original ResearchMeSH KeywordsDrug Resistance, BacterialHumansImmune Reconstitution Inflammatory SyndromeMycobacterium tuberculosisTuberculosis